Last update 12 Nov 2024

Tandutinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tandutinib (USAN/INN), 坦度替尼, CT-53518
+ [6]
Mechanism
FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), PDGFRα inhibitors(Platelet-derived growth factor receptor alpha inhibitors), PDGFRβ inhibitors(Platelet-derived growth factor receptor beta inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC31H42N6O4
InChIKeyUXXQOJXBIDBUAC-UHFFFAOYSA-N
CAS Registry387867-13-2

External Link

KEGGWikiATCDrug Bank
D06005--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 2-27 Feb 2006
GlioblastomaPhase 2
US
-
Renal Cell CarcinomaPhase 2--
Glioblastoma MultiformePhase 1-01 Jun 2009
Myelodysplastic SyndromesPhase 1
US
01 May 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
10
laboratory biomarker analysis+tandutinib
pmrwzjiafc(zmycchdqnu) = rsvuzjcpol nnlfytrssb (wlxsafhdpp, ljhsuqnule - aivygtqyug)
-
04 Feb 2015
Phase 2
18
hnhlkaafoi(pbarlnkgiq) = paserertgn czuwjmrlbg (bwpwvmoedi )
-
01 Oct 2011
Phase 2
18
iomqhlsoyf(zhwjjggsxr) = rhvjoakefi pgpuxvlpcr (snhdkthjor, iekgmctzoi - oqpanndisb)
-
07 Jun 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free